Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva J A van Wanrooij

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cardiovascular Research|February 6, 2008
Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Paula de Vos, M Gabriele Bixel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2006
Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Gijs H M van Puijvelde, Paula de Vos, et al.
Thrombosis and Haemostasis|August 5, 2009
Effect of natural killer T cell activation on the initiation of atherosclerosisGijs H M van Puijvelde, Eva J A van Wanrooij, Arnaud D Hauer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2005
HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Hester Happé, Arnaud D Hauer, et al.
Current Opinion in Lipidology|September 22, 2007
Immunomodulation of the inflammatory response in atherosclerosisJohan Kuiper, Gijs H M van Puijvelde, Eva J A van Wanrooij, et al.
Experimental Hematology|November 3, 2005
HDL cholesterol levels are an important factor for determining the lifespan of erythrocytesIlliana Meurs, Menno Hoekstra, Eva J A van Wanrooij, et al.
Atherosclerosis|November 22, 2008
Vaccination against TIE2 reduces atherosclerosisArnaud D Hauer, Kim L L Habets, Eva J A van Wanrooij, et al.
Vaccine|December 1, 2010
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient miceThomas van Es, Gijs H M van Puijvelde, Ingrid N Michon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2006
KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1Reinier A Boon, Joost O Fledderus, Oscar L Volger, et al.
Journal of Lipid Research|August 4, 2006
Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type dietMenno Hoekstra, Miranda Stitzinger, Eva J A van Wanrooij, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cardiovascular Research|February 6, 2008
Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Paula de Vos, M Gabriele Bixel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2006
Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Gijs H M van Puijvelde, Paula de Vos, et al.
Thrombosis and Haemostasis|August 5, 2009
Effect of natural killer T cell activation on the initiation of atherosclerosisGijs H M van Puijvelde, Eva J A van Wanrooij, Arnaud D Hauer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2005
HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient miceEva J A van Wanrooij, Hester Happé, Arnaud D Hauer, et al.
Current Opinion in Lipidology|September 22, 2007
Immunomodulation of the inflammatory response in atherosclerosisJohan Kuiper, Gijs H M van Puijvelde, Eva J A van Wanrooij, et al.
Experimental Hematology|November 3, 2005
HDL cholesterol levels are an important factor for determining the lifespan of erythrocytesIlliana Meurs, Menno Hoekstra, Eva J A van Wanrooij, et al.
Atherosclerosis|November 22, 2008
Vaccination against TIE2 reduces atherosclerosisArnaud D Hauer, Kim L L Habets, Eva J A van Wanrooij, et al.
Vaccine|December 1, 2010
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient miceThomas van Es, Gijs H M van Puijvelde, Ingrid N Michon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2006
KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1Reinier A Boon, Joost O Fledderus, Oscar L Volger, et al.
Journal of Lipid Research|August 4, 2006
Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type dietMenno Hoekstra, Miranda Stitzinger, Eva J A van Wanrooij, et al.
Pageof 2